Table 2 Risk of glaucoma according to diabetes status.
From: Association between diabetes status and subsequent onset of glaucoma in postmenopausal women
Diabetes status | N | Glaucoma | Duration | Incidence rate* | Model 1 | Model 2 | Model 3 |
|---|---|---|---|---|---|---|---|
No diabetes | 867,390 | 24,264 | 7,098,664.23 | 3.418 | 1 (Ref.) | 1 (Ref.) | 1 (Ref.) |
Impaired fasting glucose | 328,736 | 10,023 | 2,675,849.58 | 3.745 | 1.097 (1.072,1.123) | 1.058 (1.034,1.083) | 1.061 (1.036,1.086) |
New onset diabetes | 35,439 | 1187 | 283,958.39 | 4.180 | 1.226 (1.157,1.300) | 1.141 (1.076,1.210) | 1.151 (1.086,1.220) |
Diabetes treated with oral hypoglycemic medication | 119,552 | 5410 | 951,438.58 | 5.686 | 1.672 (1.624,1.722) | 1.445 (1.402,1.489) | 1.449 (1.406,1.493) |
Diabetes treated with insulin | 21,123 | 1174 | 158,184.39 | 7.421 | 2.2 (2.075,2.333) | 1.882 (1.774,1.996) | 1.884 (1.777,1.999) |
P-value | < .0001 | < .0001 | < .0001 | ||||
* | per 1000 | ||||||
Model 1 | Non-adjusted | ||||||
Model 2 | Adjusted for age, income, smoking, drinking, exercise, body mass index | ||||||
Model 3 | Adjusted for age, income, smoking, drinking, exercise, body mass index, and reproductive factors including parity, breastfeeding, oral contraceptive use, age at menarche, age at menopause, and hormone replacement therapy | ||||||
